Pahayahay, Rolando D.
HRN: 20-37-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/29/2023
08/05/2023
IV
4.5 G
Q8h
To Continue For 7 More Days
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominalUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes